CSPC Innovation Pharmaceutical (SHE:300765) recorded an attributable net profit of 1.26 billion yuan in the first half from an attributable net loss of 2.7 million yuan a year ago.
EPS was 0.9056 yuan, compared with net loss per share of 0.002 yuan previously, according to a Shenzhen Stock Exchange filing on Tuesday.
Operating revenue jumped 209% to 3.24 billion yuan from 1.05 billion yuan.